Drug profile · INN
amiloride hydrochloride
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
amiloride hydrochloride (AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) is a amiloride-sensitive sodium channel, enac blocker. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Drug details — amiloride hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 1
- Data quality
- 0.89
Quick answer
amiloride hydrochloride (AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) is a amiloride-sensitive sodium channel, enac blocker. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Amiloride-sensitive sodium channel, ENaC blocker
Primary target: Amiloride-sensitive sodium channel, ENaC
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is amiloride hydrochloride?
amiloride hydrochloride (AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE) is a amiloride-sensitive sodium channel, enac blocker. Associated with Teva Pharma GmbH. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for amiloride hydrochloride?
AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is a marketed brand name for amiloride hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of amiloride hydrochloride?
amiloride hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.